• Prices’ titles, “MAG 7” income, the American job report and the PCE inflation data will be at the point this week.
• Meta should report higher profits than dead due to improving the digital advertising market, making it an attractive actions to buy.
• Diving of the expected profits from Pfizer and the drop in sales suggest a more cautious approach.
• Are you looking for more usable commercial ideas? Subscribe here for 50% reduction on InvestingPro!
On Friday, the stock market ended, the main averages recording net gains for the week motivated by hopes for a de-escalation of the United States’s trade war.
It increased by 2.5%for the week, the leap of 4.6%, while the technology gain climbed by 6.7%.
Source: Investing.com
More volatility could be in store this week while investors continue to assess the prospects of the economy, inflation, interest rates and business profits in the middle of the trade war of President Donald Trump.
Wall Street’s first quarter of the first quarter of the first quarter of the massive technological actions of “Magnifiment Seven” planned to report their latest results. Microsoft (Nasdaq 🙂 and Meta Platforms (Nasdaq 🙂 Report Wednesday evening, while Apple (Nasdaq 🙂 and Amazon (Nasdaq 🙂 are hard on Thursday.
The other high-level companies on the agenda include Qualcomm (Nasdaq :), Exxonmobil (Nyse :), Chevron (nyse :), Eli Lilly (nyse :), pfizer (nyse :), coca-cola (nyse 🙂 robinhood (nasdaq :), paypal (nasdaq :), visa (nyse 🙂 :).
Meanwhile, the US employment report on Friday, the most important on the economic calendar will be Friday’s American employment report, which should show that the economy added 129,000 jobs in April. The unemployment rate is considered stable at 4.2%.
Source: Investing.com
In addition to the monthly job report, there are also important GDP data, as well as the basic PCE price index, which is Fed’s favorite inflation gauge.
Whatever management of management, below, I highlight a title likely to be in demand and another which could see a new drawback. Remember, however, …
..